Zobrazeno 1 - 4
of 4
pro vyhledávání: '"J L Marvaldi"'
Publikováno v:
Cancer research. 60(7)
Resistance of cancer cells against apoptosis induced by death factors contributes to the limited efficiency of immune- and drug-induced destruction of tumors. We report here that insulin and insulin-like growth factor-I (IGF-I) fully protect HT29-D4
Publikováno v:
Endocrinology. 138(5)
To assess the autocrine function of insulin-like growth factor II (IGF-II) in the balance of proliferation and differentiation in HT29-D4 human colonic cancer cells, we studied the expression of IGF-I receptors (IGF-IR) and insulin receptors (IR) in
Autor:
F L Garrouste, M M Remacle-Bonnet, C Rabenandrasana, J L Marvaldi, Gilbert Pommier, J M Culouscou
Publikováno v:
Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 1992, 75 (2), pp.609-616. ⟨10.1210/jcem.75.2.1322432⟩
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 1992, 75 (2), pp.609-616. ⟨10.1210/jcem.75.2.1322432⟩
International audience; The HT29 human colonic carcinoma cell line secretes insulin-like growth factor (IGF)-II. We have examined these cells for expression of IGF receptors. Competitive binding assays as affinity cross-linking experiments using 125I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d041aaca34f5eeffaf7339a6e0871490
https://hal.archives-ouvertes.fr/hal-02136045
https://hal.archives-ouvertes.fr/hal-02136045
Publikováno v:
Cancer research. 52(11)
Suramin, a drug that binds to several types of growth factors, has been previously shown to induce the enterocyte-like differentiation of HT29-D4 human colonic adenocarcinoma cells, suggesting that growth factors are involved in such a process. Undif